Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michel Geist

Enveloped Virus Is the Major Virus Form Produced During Productive Infection With the Modified Vaccinia Virus Ankara Strain

Virology

2000

English

Tumor Gene Therapy by MVA-mediated Expression of T-Cell–stimulating Antibodies

English

Related publications

Chemokine (C-C Motif) Receptor 1 Is Required for Efficient Recruitment of Neutrophils During Respiratory Infection With Modified Vaccinia Virus Ankara

English

The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus

English

Povidone-Iodine Hand Wash and Hand Rub Products Demonstrated Excellent in Vitro Virucidal Efficacy Against Ebola Virus and Modified Vaccinia Virus Ankara, the New European Test Virus for Enveloped Viruses

BMC Infectious Diseases

Infectious Diseases

2015

English

834 Rational Design of Recombinant Modified Vaccinia Virus Ankara for Cancer Immunotherapy

Journal of Investigative Dermatology

English

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

English

Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice Against Lethal Challenge

PLoS Neglected Tropical Diseases

English

Immunogenic Cell Death of Dendritic Cells Following Modified Vaccinia Virus Ankara Infection Enhances CD8+ T Cell Proliferation

European Journal of Immunology

Allergy

Immunology

2018

English

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

English

Recombinant Modified Vaccinia Virus Ankara Expressing the Surface Gp120 of Simian Immunodeficiency Virus (SIV) Primes for a Rapid Neutralizing Antibody Response to SIV Infection in Macaques

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michel Geist

Enveloped Virus Is the Major Virus Form Produced During Productive Infection With the Modified Vaccinia Virus Ankara Strain

Tumor Gene Therapy by MVA-mediated Expression of T-Cell–stimulating Antibodies

Related publications

Chemokine (C-C Motif) Receptor 1 Is Required for Efficient Recruitment of Neutrophils During Respiratory Infection With Modified Vaccinia Virus Ankara

The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus

Povidone-Iodine Hand Wash and Hand Rub Products Demonstrated Excellent in Vitro Virucidal Efficacy Against Ebola Virus and Modified Vaccinia Virus Ankara, the New European Test Virus for Enveloped Viruses

834 Rational Design of Recombinant Modified Vaccinia Virus Ankara for Cancer Immunotherapy

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice Against Lethal Challenge

Immunogenic Cell Death of Dendritic Cells Following Modified Vaccinia Virus Ankara Infection Enhances CD8+ T Cell Proliferation

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

Recombinant Modified Vaccinia Virus Ankara Expressing the Surface Gp120 of Simian Immunodeficiency Virus (SIV) Primes for a Rapid Neutralizing Antibody Response to SIV Infection in Macaques